sumatriptan has been researched along with clonidine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (25.00) | 18.2507 |
| 2000's | 13 (54.17) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| DeLannoy, I; Dukat, M; Glennon, RA; Law, H; MacLean, N; Prisinzano, T; Slassi, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Callaghan, N | 1 |
| Green, C | 1 |
| Bento, A; Dieguez, C; Mota, A; Peñalva, A; Pombo, M | 1 |
| de Lima, VM; Hanke, W; Wiedemann, M | 1 |
| Jin, S; Liu, Z; Tian, Y; Zhang, C | 1 |
| Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
| Caenepeel, P; Corsetti, M; Janssens, J; Tack, J | 1 |
| Boesiger, P; Brasseur, JG; Forras-Kaufman, Z; Fox, MR; Fried, M; Fruehauf, H; Goetze, O; Hebbard, GS; Kaufman, E; Kwiatek, MA; Menne, D; Pal, A; Schwizer, W; Steingoetter, A; Thumshirn, M | 1 |
| Truter, I | 1 |
1 review(s) available for sumatriptan and clonidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for sumatriptan and clonidine
| Article | Year |
|---|---|
Clinical study of epidural analgesia with clonidine and sumatriptan in posthysterectomy.
Topics: Adult; Analgesia, Epidural; Analgesics, Non-Narcotic; Animals; Clonidine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hysterectomy; Injections, Spinal; Middle Aged; Pain, Postoperative; Serotonin Receptor Agonists; Sumatriptan | 1997 |
Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
Topics: Adrenergic alpha-Agonists; Adult; Blood Pressure; Clonidine; Gastric Emptying; Gastrointestinal Motility; Heart Rate; Humans; Magnetic Resonance Imaging; Manometry; Organ Size; Peristalsis; Postprandial Period; Pyloric Antrum; Serotonin Receptor Agonists; Stomach; Sumatriptan | 2009 |
21 other study(ies) available for sumatriptan and clonidine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
2-(Anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands.
Topics: Adenylyl Cyclases; Aniline Compounds; Animals; Benzyl Compounds; Humans; Imidazolines; In Vitro Techniques; Ligands; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1D; Saphenous Vein; Serotonin Receptor Agonists; Structure-Activity Relationship | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Management of migraine.
Topics: Adrenal Cortex Hormones; Aspirin; Clonidine; Humans; Indoles; Migraine Disorders; Propranolol; Sulfonamides; Sumatriptan | 1992 |
Sumatriptan and other drugs used in migraine treatment.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Clonidine; Contraindications; Cyproheptadine; Humans; Indoles; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Topics: Arginine; Child; Clonidine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Obesity; Pituitary Gland, Anterior; Prolactin; Pyridostigmine Bromide; Receptors, Serotonin; Sumatriptan; Thyrotropin; Thyrotropin-Releasing Hormone | 1995 |
Effects of antimigraine drugs on retinal spreading depression.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Adrenochrome; Analgesics, Non-Narcotic; Animals; Aspirin; Chickens; Clonidine; Cortical Spreading Depression; Cyclooxygenase Inhibitors; Electrophysiology; Ergotamine; Image Processing, Computer-Assisted; Indolequinones; Lisuride; Methysergide; Migraine Disorders; Neurons; Propranolol; Retina; Serotonin Antagonists; Sumatriptan; Videotape Recording | 1996 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention.
Topics: Adult; Clonidine; Dyspepsia; Female; Gastric Dilatation; Humans; Male; Mechanoreceptors; Perception; Pressure; Sumatriptan | 2004 |
Prescribing patterns of anti-migraine medicines in South Africa using a claims database.
Topics: Adult; Clonidine; Databases, Factual; Drugs, Generic; Female; Humans; Insurance, Health, Reimbursement; Male; Migraine Disorders; Practice Patterns, Physicians'; Retrospective Studies; Serotonin Receptor Agonists; South Africa; Sumatriptan; Young Adult | 2015 |